"After converting to Masimo SET, we noticed a significant decrease in false alarms," said Dr. Stephen Snyder, Neonatologist at Abington Memorial Hospital. "In the past, other monitors would falsely alarm in the presence of motion or low perfusion, which would prolong the patients' length of stay. Hospital protocols dictate that if a neonatal patient has a significant SpO2 alarm during the last 24 hours of their stay, they are required to be monitored longer before they can be discharged."
In addition to Abington Memorial Hospital's system-wide standardization to Masimo SET pulse oximetry, the conversion also allows hospital clinicians to utilize Masimo Rainbow SET technology. Masimo Rainbow SET is an upgradable noninvasive blood constituent monitoring platform that is capable of measuring additional blood constituents that previously required invasive procedures. Masimo Rainbow SET's first application is Pulse CO-Oximetry, the first and only technology platform capable of continuously and noninvasively measuring carboxyhemoglobin (SpCO) and methemoglobin (SpMet), in addition to oxyhemoglobin (SpO2), perfusion index (PI), pleth variability index (PVI) and pulse rate.
Joe E. Kiani, CEO of Masimo, stated, "Abington Memorial Hospital is a
large and growing teaching hospital in the Philadelphia suburbs that is
setting the pace for the next-generation of hospital physicians,
specialists and clinical staff. This conversion is especially rewarding
because they have chosen Masimo SET and Masimo Rainbow SET technologies to
prepare their future generations of healthcare professionals. We are proud
that Masimo SET is the pulse oximetry standard of care at work in Abington
Copyright©2008 PR Newswire.
All rights reserved